506 related articles for article (PubMed ID: 11732637)
1. Pharmacology of appetite suppression: implication for the treatment of obesity.
Halford JC
Curr Drug Targets; 2001 Dec; 2(4):353-70. PubMed ID: 11732637
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of appetite suppression.
Halford JC; Blundell JE
Prog Drug Res; 2000; 54():25-58. PubMed ID: 10857385
[TBL] [Abstract][Full Text] [Related]
3. The pharmacology of human appetite expression.
Halford JC; Cooper GD; Dovey TM
Curr Drug Targets; 2004 Apr; 5(3):221-40. PubMed ID: 15058309
[TBL] [Abstract][Full Text] [Related]
4. Separate systems for serotonin and leptin in appetite control.
Halford JC; Blundell JE
Ann Med; 2000 Apr; 32(3):222-32. PubMed ID: 10821329
[TBL] [Abstract][Full Text] [Related]
5. Behavioural satiety sequence (BSS): separating wheat from chaff in the behavioural pharmacology of appetite.
Rodgers RJ; Holch P; Tallett AJ
Pharmacol Biochem Behav; 2010 Nov; 97(1):3-14. PubMed ID: 20214921
[TBL] [Abstract][Full Text] [Related]
6. Drug strategies for the treatment of obesity.
Alemany M; Remesar X; Fernández-López JA
IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679
[TBL] [Abstract][Full Text] [Related]
7. Neuropharmacology of human appetite expression.
Halford JC; Harrold JA
Dev Disabil Res Rev; 2008; 14(2):158-64. PubMed ID: 18646016
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological aspects of appetite: implications for the treatment of obesity.
Blundell JE; Greenough A
Biomed Pharmacother; 1994; 48(3-4):119-25. PubMed ID: 7993976
[TBL] [Abstract][Full Text] [Related]
9. Afferent signals regulating food intake.
Bray GA
Proc Nutr Soc; 2000 Aug; 59(3):373-84. PubMed ID: 10997653
[TBL] [Abstract][Full Text] [Related]
10. Diet, monoamine neurotransmitters and appetite control.
Fernstrom JD; Fernstrom MH
Nestle Nutr Workshop Ser Clin Perform Programme; 2001; 5():117-31; discussion 131-3. PubMed ID: 11510434
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system biogenic amine targets for control of appetite and energy expenditure.
Nelson DL; Gehlert DR
Endocrine; 2006 Feb; 29(1):49-60. PubMed ID: 16622292
[TBL] [Abstract][Full Text] [Related]
12. [The regulation of body mass and its relation to the development of obesity].
Juhász A; Katona E; Csongrádi E; Paragh G
Orv Hetil; 2007 Sep; 148(39):1827-36. PubMed ID: 17890170
[TBL] [Abstract][Full Text] [Related]
13. Strategies and potential molecular targets for obesity treatment.
Campfield LA; Smith FJ; Burn P
Science; 1998 May; 280(5368):1383-7. PubMed ID: 9603722
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine control of food intake.
Valassi E; Scacchi M; Cavagnini F
Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):158-68. PubMed ID: 18061414
[TBL] [Abstract][Full Text] [Related]
15. Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity.
Halford JC; Harrold JA; Lawton CL; Blundell JE
Curr Drug Targets; 2005 Mar; 6(2):201-13. PubMed ID: 15777190
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological approaches for the treatment of obesity.
Fernández-López JA; Remesar X; Foz M; Alemany M
Drugs; 2002; 62(6):915-44. PubMed ID: 11929339
[TBL] [Abstract][Full Text] [Related]
17. The hypothalamus and the regulation of energy homeostasis: lifting the lid on a black box.
Williams G; Harrold JA; Cutler DJ
Proc Nutr Soc; 2000 Aug; 59(3):385-96. PubMed ID: 10997654
[TBL] [Abstract][Full Text] [Related]
18. Neuro-hormonal control of food intake: basic mechanisms and clinical implications.
Konturek PC; Konturek JW; Cześnikiewicz-Guzik M; Brzozowski T; Sito E; Konturek SJ
J Physiol Pharmacol; 2005 Dec; 56 Suppl 6():5-25. PubMed ID: 16340035
[TBL] [Abstract][Full Text] [Related]
19. [The pharmacotherapy of obesity].
Budai KA; Mirzahosseini A; Noszál Béla ; Tóth G
Acta Pharm Hung; 2015; 85(1):3-17. PubMed ID: 26137782
[TBL] [Abstract][Full Text] [Related]
20. Is there appetite after GLP-1 and PACAP?
Christophe J
Ann N Y Acad Sci; 1998 Dec; 865():323-35. PubMed ID: 9928026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
